Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|October 15, 2015
Advanced technologies and diagnostic spin-outs: an interview with Carl BorrebaeckCarl BorrebaeckAnalytical Biochemistry|September 6, 2005
Gravimetric antigen detection utilizing antibody-modified lipid bilayersCharlotte Larsson, Hanna Bramfeldt, Christer Wingren, et al.Toxicology Letters|November 26, 2005
Interactions between dendritic cells and epithelial cells in allergic diseaseErwin L Roggen, Malin Lindstedt, Carl Borrebaeck, et al.Glycobiology|April 8, 2011
A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activityCharlotte Welinder, Bo Baldetorp, Carl Borrebaeck, et al.BMC Pharmacology & Toxicology|February 13, 2014
Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potencyAnn-Sofie Albrekt, Henrik Johansson, Anna Börje, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|March 29, 2014
Genomic allergen rapid detection in-house validation--a proof of conceptHenrik Johansson, Frida Rydnert, Jochen Kühnl, et al.BMC Cancer|June 29, 2012
Expanded clinical and experimental use of SOX11 - using a monoclonal antibodyLena Nordström, Ulrika Andréasson, Mats Jerkeman, et al.New Biotechnology|August 6, 2017
Combination of phage and Gram-positive bacterial display of human antibody repertoires enables isolation of functional high affinity bindersFrancis Jingxin Hu, Anna-Luisa Volk, Helena Persson, et al.Cancer Management and Research|December 3, 2020
Psychological Resilience and Health-Related Quality of Life in Swedish Women with Newly Diagnosed Breast CancerÅsa Mohlin, Ulrika Axelsson, Pär-Ola Bendahl, et al.ALTEX|February 20, 2017
Evaluation of the GARD assay in a blind Cosmetics Europe studyHenrik Johansson, Robin Gradin, Andy Forreryd, et al.Pageof 2